Anti-NAV3 monoclonal antibody

Pre-made anti-NAV3 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to NAV3/NAV3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1238-Ab-1/ GM-Tg-hg-IP1238-Ab-2Anti-Human NAV3 monoclonal antibodyHuman
GM-Tg-rg-IP1238-Ab-1/ GM-Tg-rg-IP1238-Ab-2Anti-Rat NAV3 monoclonal antibodyRat
GM-Tg-mg-IP1238-Ab-1/ GM-Tg-mg-IP1238-Ab-2Anti-Mouse NAV3 monoclonal antibodyMouse
GM-Tg-cynog-IP1238-Ab-1/ GM-Tg-cynog-IP1238-Ab-2Anti-Cynomolgus/ Rhesus macaque NAV3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1238-Ab-1/ GM-Tg-felg-IP1238-Ab-2Anti-Feline NAV3 monoclonal antibodyFeline
GM-Tg-cang-IP1238-Ab-1/ GM-Tg-cang-IP1238-Ab-2Anti-Canine NAV3 monoclonal antibodyCanine
GM-Tg-bovg-IP1238-Ab-1/ GM-Tg-bovg-IP1238-Ab-2Anti-Bovine NAV3 monoclonal antibodyBovine
GM-Tg-equg-IP1238-Ab-1/ GM-Tg-equg-IP1238-Ab-2Anti-Equine NAV3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1238-Ab-1/ GM-Tg-hg-IP1238-Ab-2; GM-Tg-rg-IP1238-Ab-1/ GM-Tg-rg-IP1238-Ab-2;
GM-Tg-mg-IP1238-Ab-1/ GM-Tg-mg-IP1238-Ab-2; GM-Tg-cynog-IP1238-Ab-1/ GM-Tg-cynog-IP1238-Ab-2;
GM-Tg-felg-IP1238-Ab-1/ GM-Tg-felg-IP1238-Ab-2; GM-Tg-cang-IP1238-Ab-1/ GM-Tg-cang-IP1238-Ab-2;
GM-Tg-bovg-IP1238-Ab-1/ GM-Tg-bovg-IP1238-Ab-2; GM-Tg-equg-IP1238-Ab-1/ GM-Tg-equg-IP1238-Ab-2
Products NameAnti-NAV3 monoclonal antibody
Formatmab
Target NameNAV3
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-NAV3 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1238-Ag-1Recombinant multi-species NAV3/ POMFIL1/ STEERIN3 protein


    Target information

    Target IDGM-IP1238
    Target NameNAV3
    Gene ID89795,260315,314814,694815,482577,101088856,528870,100050448
    Gene Symbol and Synonyms4732483H20Rik,9630020C08Rik,mKIAA0938,NAV3,POMFIL1,Pomfil1p,RGD1306259,STEERIN3,unc53H3
    Uniprot AccessionQ8IVL0
    Uniprot Entry NameNAV3_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000067798
    Target ClassificationN/A

    The target: NAV3, gene name: NAV3, also named as POMFIL1, STEERIN3, unc53H3. This gene belongs to the neuron navigator family and is expressed predominantly in the nervous system. The encoded protein contains coiled-coil domains and a conserved AAA domain characteristic for ATPases associated with a variety of cellular activities. This gene is similar to unc-53, a Caenorhabditis elegans gene involved in axon guidance. Multiple alternatively spliced transcript variants for this gene have been described but only one has had its full-length nature determined. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.